Shots: Cerecor acquires Aevi Genomic Medicine in an all-stock transaction for $16.1M upfront + $2M (cash/ stock) as CVR on the enrollment of P-II study of AEVI-002, AEVI-006 or AEVI-007 […]readmore
Tags : Aevi Genomic Medicine
Shots: AstraZeneca to receive option exercise fee in cash and equity, up to $162M as development & commercial milestones and royalties on global sales Aevi Genomic to get an option […]readmore